The Nasdaq Composite, S&P 500 and Dow industrials all shed 2.5% or more Thursday as stocks gave back part of the historic gains that followed President Trump's decision Wednesday for a 90-day tariff pause. The$Nasdaq Composite Index (.IXIC.US)$led the way downward Thursday, sinking 737.66 points (4.3%) to a 16,387.31 close. Meanwhile, the$S&P 500 Index (.SPX.US)$gave up 188.85 ticks (3.4%) to...
72137141
:
it was a market manipulation by the fascist Tramp government.... what's new? they're criminals Yes, market manipulation is a crime in most countries, including the United States. It involves deliberately interfering with the free and fair operation of a market, often to create artificial prices or trading volumes for personal gain.
Ultratech
72137141
:
he's above the law apparently. the January 6th riot wasn't supposed to be able to run. stealing classified documents rapist tax evasion etc
The Nasdaq Composite, S&P 500 and Dow industrials all scored their biggest one-day gains in years on Wednesday after U.S. President Donald Trump paused much of his massive tariff package on foreign imports for 90 days. The$Nasdaq Composite Index (.IXIC.US)$led the way higher, soaring 1,857.06 points (12.2%) to a 17,124.97 close. That's the index's largest one-day percentage gain since 2001, as wel...
Weg
:
Guy throws on massive tarrifs, crashes the market, goes long, pauses tarrifs, makes millions, pardon yourself. God its fucking too easy being the president
Despite Neogen's profitability and revenue growth, its share price drop is surprising and needs further investigation. The company's future earnings are crucial for shareholders. The recent loss is less severe than the 8% annual loss over the last half decade. Clear growth indications are needed before assuming share price stability.
The drop in stock price is in line with the decline in Neogen's earnings, which is expected under normal market conditions. The recent insider buying may suggest some confidence in the company's future prospects despite the slump in financial performance.
$MorphoSys (MOR.US)$initiated at overweight by Wells Fargo, announced target price at $17.00. $Guess (GES.US)$initiated at neutral by UBS, announced targe price at $22.00. $West Pharmaceutical Services (WST.US)$was upgraded by Bank of America Securities from neutral to buy, increased target price from $390.00 to $405.00. $AutoZone (AZO.US)$was upgraded by UBS from neutral to buy, increased target price from $2800.00 to $2900.00. $RPC Inc (RES.US)$was downgr...
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Neogen Stock Forum
The $Nasdaq Composite Index (.IXIC.US)$ led the way downward Thursday, sinking 737.66 points (4.3%) to a 16,387.31 close.
Meanwhile, the $S&P 500 Index (.SPX.US)$ gave up 188.85 ticks (3.4%) to...
The $Nasdaq Composite Index (.IXIC.US)$ led the way higher, soaring 1,857.06 points (12.2%) to a 17,124.97 close. That's the index's largest one-day percentage gain since 2001, as wel...
$Guess (GES.US)$initiated at neutral by UBS, announced targe price at $22.00.
$West Pharmaceutical Services (WST.US)$was upgraded by Bank of America Securities from neutral to buy, increased target price from $390.00 to $405.00.
$AutoZone (AZO.US)$was upgraded by UBS from neutral to buy, increased target price from $2800.00 to $2900.00.
$RPC Inc (RES.US)$was downgr...
No comment yet